Total Payments
$125,423
2023 Payments
$128.49
Companies
4
Transactions
28
Medicare Patients
2,025
Medicare Billing
$49,576
Payment Breakdown by Category
Consulting$124,270 (99.1%)
Travel$917.66 (0.7%)
Food & Beverage$234.91 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $124,270 | 17 | 99.1% |
| Travel and Lodging | $917.66 | 5 | 0.7% |
| Food and Beverage | $234.91 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $118,900 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $2,753 | 2 | $0 (2022) |
| AstraZeneca UK Limited | $2,685 | 1 | $0 (2022) |
| Siemens Medical Solutions USA, Inc. | $1,085 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $128.49 | 2 | Siemens Medical Solutions USA, Inc. ($128.49) |
| 2022 | $5,438 | 3 | AstraZeneca Pharmaceuticals LP ($2,753) |
| 2019 | $28,500 | 2 | Merck Sharp & Dohme Corporation ($28,500) |
| 2018 | $41,800 | 4 | Merck Sharp & Dohme Corporation ($41,800) |
| 2017 | $49,556 | 17 | Merck Sharp & Dohme Corporation ($48,600) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2023 | Siemens Medical Solutions USA, Inc. | NAEOTOM Alpha (Device) | Food and Beverage | In-kind items and services | $58.20 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 03/06/2023 | Siemens Medical Solutions USA, Inc. | NAEOTOM Alpha (Device) | Food and Beverage | In-kind items and services | $70.29 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| Category: Oncology | ||||||
| 06/27/2022 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| 06/09/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $67.80 | General |
| 02/28/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $17,100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/03/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $11,400.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $15,900.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/25/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $21,900.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/09/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/12/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/05/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $12,600.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/17/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/27/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/06/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $8,100.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/11/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/17/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Travel and Lodging | In-kind items and services | $56.92 | General |
| Category: DI - X-Ray Products | ||||||
| 02/17/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Travel and Lodging | In-kind items and services | $54.07 | General |
| Category: DI - X-Ray Products | ||||||
| 02/17/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: DI - X-Ray Products | ||||||
| 02/17/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: MR - MRI | ||||||
| 02/17/2017 | Siemens Medical Solutions USA, Inc. | Non-Product Specific (Device) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: DI - X-Ray Products | ||||||
| 02/16/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 133 | 133 | $11,956 | $3,117 |
| 2022 | 10 | 561 | 572 | $51,604 | $15,089 |
| 2021 | 11 | 693 | 703 | $58,372 | $16,294 |
| 2020 | 10 | 638 | 643 | $53,732 | $15,075 |
Total Patients
2,025
Total Services
2,051
Medicare Billing
$49,576
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 28 | 28 | $3,696 | $1,042 | 28.2% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 11 | 11 | $1,452 | $576.73 | 39.7% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 15 | 15 | $1,950 | $451.94 | 23.2% |
| 74220 | Single contrast x-ray of esophagus | Facility | 2023 | 18 | 18 | $936.00 | $353.10 | 37.7% |
| 74230 | Imaging for evaluation of swallowing function | Facility | 2023 | 17 | 17 | $2,822 | $353.09 | 12.5% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 44 | 44 | $1,100 | $340.80 | 31.0% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 125 | 126 | $16,632 | $5,232 | 31.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2022 | 18 | 18 | $3,330 | $1,678 | 50.4% |
| 71046 | X-ray of chest, 2 views | Facility | 2022 | 187 | 197 | $4,920 | $1,651 | 33.6% |
| 74230 | Imaging for evaluation of swallowing function | Facility | 2022 | 74 | 74 | $12,284 | $1,522 | 12.4% |
| 74220 | Single contrast x-ray of esophagus | Facility | 2022 | 59 | 59 | $3,068 | $1,397 | 45.5% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2022 | 22 | 22 | $2,904 | $1,169 | 40.3% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 13 | 13 | $3,250 | $931.28 | 28.7% |
| 70486 | Ct scan of face without contrast | Facility | 2022 | 28 | 28 | $3,640 | $919.38 | 25.3% |
| 78580 | Nuclear medicine study of lung circulation | Facility | 2022 | 13 | 13 | $1,092 | $374.43 | 34.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2022 | 22 | 22 | $484.00 | $215.18 | 44.5% |
| 71250 | Diagnostic ct scan of chest | Facility | 2021 | 131 | 134 | $17,688 | $5,749 | 32.5% |
| 71046 | X-ray of chest, 2 views | Facility | 2021 | 223 | 230 | $5,750 | $1,960 | 34.1% |
| 74230 | Imaging for evaluation of swallowing function | Facility | 2021 | 87 | 87 | $14,442 | $1,865 | 12.9% |
| 70486 | Ct scan of face | Facility | 2021 | 40 | 40 | $5,200 | $1,315 | 25.3% |
| 74220 | X-ray of esophagus with single contrast | Facility | 2021 | 50 | 50 | $2,600 | $1,202 | 46.2% |
| 71275 | Ct scan of blood vessels in chest with contrast | Facility | 2021 | 14 | 14 | $3,500 | $1,012 | 28.9% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 36 | 36 | $2,880 | $1,011 | 35.1% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2021 | 26 | 26 | $3,370 | $1,005 | 29.8% |
| 78580 | Nuclear medicine study of blood circulation in the lungs | Facility | 2021 | 18 | 18 | $1,512 | $524.52 | 34.7% |
About Dr. Debra Dyer, M.D
Dr. Debra Dyer, M.D is a Diagnostic Radiology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124111810.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Dyer, M.D has received a total of $125,423 in payments from pharmaceutical and medical device companies, with $128.49 received in 2023. These payments were reported across 28 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($124,270).
As a Medicare-enrolled provider, Dyer has provided services to 2,025 Medicare beneficiaries, totaling 2,051 services with total Medicare billing of $49,576. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Denver, CO
- Active Since 10/02/2006
- Last Updated 02/22/2021
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1124111810
Products in Payments
- NOXAFIL (Drug) $118,900
- TAGRISSO (Drug) $2,685
- Non-Product Specific (Device) $956.28
- NAEOTOM Alpha (Device) $128.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Denver
James Ingram, M.d, M.D
Diagnostic Radiology — Payments: $811,427
Diagnostic Radiology $811,427
David Lynch, Md, MD
Diagnostic Radiology — Payments: $305,129
Diagnostic Radiology $305,129
Seth Kligerman, Md, MD
Diagnostic Radiology — Payments: $56,499
Diagnostic Radiology $56,499
Katherine Parker, Md, MD
Diagnostic Radiology — Payments: $13,683
Diagnostic Radiology $13,683
Dr. Stephen Dreyer, M.d, M.D
Diagnostic Radiology — Payments: $5,049
Diagnostic Radiology $5,049
Dr. Sharon Kwan, M.d, M.D
Diagnostic Radiology — Payments: $3,908
Diagnostic Radiology $3,908